Publication | Closed Access

Ganetespib overcomes resistance to PARP inhibitors in breast cancer by targeting core proteins in the DNA repair machinery

Drug TargetingMedicineMolecular BiologyDna Repair MachineryCancer GenomicsParp InhibitorsBreast CancerCancer BiologyRadiation OncologyNovel Therapy